Interaction of amorphous calcium phosphate with fibrin in vitro causes decreased fibrinolysis and altered protease profiles: Implications for atherosclerotic disease

Inflammation

Volumn 25, Issue 5, 2001, Pages 319-329

  Makowski, Gregory S ^a   Ramsby, Melinda L ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Amorphous calcium phosphate; Atherosclerotic disease; Fibrin; Fibrinolysis; Protease profiles

Indexed keywords

CALCIUM PHOSPHATE; FIBRIN; GELATINASE B; MATRIX METALLOPROTEINASE; PLASMIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; ALPHA TRICALCIUM PHOSPHATE; ALPHA-TRICALCIUM PHOSPHATE; CALCIUM PHOSPHATE MONOBASIC; CASEIN; DICALCIUM PHOSPHATE ANHYDROUS; GELATIN; PLASMINOGEN ACTIVATOR; PROTEINASE; TETRACALCIUM PHOSPHATE;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CORONARY ARTERY BYPASS SURGERY; ENZYME ACTIVITY; FIBRINOLYSIS; HUMAN; INFLAMMATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; UNSTABLE ANGINA PECTORIS; AGED; ARTERIOSCLEROSIS; CHEMISTRY; CORONARY ARTERY BYPASS GRAFT; DRUG EFFECT; MALE; METABOLISM; PROTEIN BINDING;

ANGINA;

AGED; AGED, 80 AND OVER; ARTERIOSCLEROSIS; CALCIUM PHOSPHATES; CASEINS; CORONARY ARTERY BYPASS; ENDOPEPTIDASES; FIBRIN; FIBRINOLYSIS; GELATIN; HUMANS; MALE; PLASMINOGEN ACTIVATORS; PROTEIN BINDING;

EID: 0035527565     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012831900153     Document Type: Article

References (42)

1. On the biological significance of the specific interaction between fibrin, plasminogen and antiplasmin
2. Fibrin polymerization and its regulatory role in hemostasis
3. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
4. Chemotaxis for human monocytes by fibrinogen-derived peptides
5. Binding of latent matrix metalloproteinase 9 to fibrin: Activation via a plasmin-dependent pathway
6. Binding of latent matrix metalloproteinase 9 to fibrin is mediated by amorphous calcium-phosphate
7. Amorphous calcium phosphate: The contention of bone
8. Mechanisms of calcification: Role of collagen, polyphosphates, and phosphatase
9. Amorphous calcium phosphate-mediated binding of matrix metalloproteinase-9 to fibrin is inhibited by pyrophosphate and bisphosphonate
10. Amorphous calcium phosphate in casein micelles of bovine milk
11. Stabilization of amorphous calcium phosphate by Mg and ATP
12. A new method for the study of the formation and transformation of calcium phosphate precipitates: Effects of several chemical agents and chinese folk medicines
13. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation
14. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis
15. Non-collagenous bone matrix proteins, calcification, and thrombosis in carotid artery atherosclerosis
16. Polymorphisms of the human matrix gla protein (MCP) gene, vascular calcification, and myocardial infarction
17. Calibrating gelatin zymograms with human gelatinase standards
18. Rapid physiological coagulation method for the determination of fibrinogen
19. Occlusion of plasma proteins by human fibrin: Studies using trace-labelled proteins
20. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
21. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates
22. pH modification to enhance the molecular seiving properties of sodium dodecyl sulfate-10% polyacrylamide gels
23. A molecular model of plasmic degradation of crosslinked fibrin
24. Overlay assay: Enzyme zymography of plasminogen activators and inhibitors
25. Fibrin induction of tissue plasminogen activator in corneal endothelial cells in vitro
26. Optimum conditions for the stabilization of tissue plasminogen activator activity in human plasma
27. Adsorption to fibrin of native fragments of known primary structure from human plasminogen
28. 2-antiplasmin and fibrin
29. An elastase-dependent pathway of plasminogen activation
30. Evidence of an active fibrinolytic enzyme in the plasma of normal people with observation on inhibition associated with the presence of calcium
31. Fibrin containing gels induce angiogenesis: Implication for tumor stroma generation and wound healing
32. Ligneous conjunctivitis: Biochemical evidence for hypofibrinolysis
33. Hypercoagulability and hypofibrinolysis in primary osteoarthritis
34. Immunolocalization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human subconjunctival tissues
35. Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis
36. A definition of advanced types of athersclerotic lesions and a histological classification of atherosclerosis
37. Mechanisms of pathologic calcification
38. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor
39. Matrix metalloproteinase inhibitor prevents acute lung injury after cardiopulmonary bypass
40. Individual variations in the fibrinolytic response during and after cardiopulmonary bypass
41. Intra- and postoperative fibrinolysis in patients undergoing cardiopulmonary bypass surgery
42. Enhanced fibrinolytic activity during cardiopulmonary bypass in open-heart surgery in man is caused by extrinsic (tissue-type) plasminogen activator